ATLANTA, GA -- (MARKET WIRE) -- February 06, 2007 -- AtheroGenics, Inc. (NASDAQ: AGIX), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, today announced that Charles A. Deignan has been promoted to Vice President of Finance and Administration and Principal Accounting Officer. Previously Senior Director of Finance and Administration, Deignan will continue to report to Mark P. Colonnese, Executive Vice President of Commercial Operations and Chief Financial Officer.
